EUVIMEDEUVIMED entdecken
Multizentrische StudieEvaluationsstudieVergleichsstudieOpen Access · CC BY 4.0

A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution

L M Koeth iD, J M DiFranco-Fisher, E Palavecino iD, A Kilic, D Hardy, D Vicino, S Stracquadanio iD, S Stefani iD

Journal of Clinical Microbiology · 19.02.2025 · 63 (2)

DOI: 10.1128/jcm.00926-24 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Clinical Microbiology, erschienen am 19.02.2025. Verfasst von L M Koeth und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Specialists, Inc., Westlake, Ohio, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Pseudomonas aeruginosa, Acinetobacter baumannii, Cephalosporins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The performance of the Liofilchem Compact Antimicrobial Susceptibility Panel (ComASP) Cefiderocol was evaluated in a multicenter study. Enterobacterales, Acinetobacter baumannii , and Pseudomonas aeruginosa clinical isolates and challenge isolates were tested by three and one sites, respectively. Minimum inhibitory concentration (MIC) testing was performed by the Clinical and Laboratory Standards Institute (CLSI) broth microdilution and ComASP, which included two reading endpoints (CLSI read; MIC is the first well in which reduction of growth is

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsPseudomonas aeruginosaAcinetobacter baumanniiCephalosporinsEnterobacteriaceaeHumansMicrobial Sensitivity TestsReproducibility of ResultsCefiderocol

Stichwörter der Autor:innen

ComASP Cefiderocolbroth microdilutionmulticenter study

Substanzen

Anti-Bacterial AgentsCefiderocolCephalosporins

Autor:innen und Institutionen

  • Laboratory Specialists, Inc., Westlake, Ohio, USA.
  • School of Medicine, Wake Forest University, Winston-Salem, North Carolina, USA.
  • Clinical Microbiology, University of Rochester Medical Center, Rochester, New York, USA.
  • Clinical Microbiology, University of Catania, Catania, Italy.

ORCID-Profile: L M Koeth, E Palavecino, S Stracquadanio, S Stefani

Zitieren

APA

Koeth, L. M., DiFranco-Fisher, J. M., Palavecino, E., Kilic, A., Hardy, D., Vicino, D., Stracquadanio, S., & Stefani, S. (2025). A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution. Journal of Clinical Microbiology, 63(2). https://doi.org/10.1128/jcm.00926-24

Vancouver

Koeth LM, DiFranco-Fisher JM, Palavecino E, Kilic A, Hardy D, Vicino D, et al. A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution. Journal of Clinical Microbiology. 2025;63(2). doi:10.1128/jcm.00926-24

BibTeX
@article{Koeth2025,
  author = {Koeth, L M and DiFranco-Fisher, J M and Palavecino, E and Kilic, A and Hardy, D and Vicino, D and Stracquadanio, S and Stefani, S},
  title = {A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution},
  journal = {Journal of Clinical Microbiology},
  year = {2025},
  volume = {63},
  number = {2},
  doi = {10.1128/jcm.00926-24}
}
Kostenlos starten →